Alcon Inc. (ALC)

NYSE: ALC · Real-Time Price · USD
75.39
-1.43 (-1.86%)
Oct 7, 2025, 3:16 PM EDT - Market open
-1.86%
Market Cap38.22B
Revenue (ttm)10.03B
Net Income (ttm)1.07B
Shares Out 494.40M
EPS (ttm)2.16
PE Ratio35.62
Forward PE23.42
Dividend$0.22 (0.29%)
Ex-Dividend DateMay 14, 2025
Volume1,391,372
Open76.73
Previous Close76.82
Day's Range75.50 - 76.78
52-Week Range73.22 - 99.20
Beta0.69
AnalystsBuy
Price Target95.55 (+26.74%)
Earnings DateNov 11, 2025

About ALC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ... [Read more]

Sector Healthcare
Founded 1945
Employees 25,599
Stock Exchange NYSE
Ticker Symbol ALC
Full Company Profile

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial Statements

Analyst Summary

According to 11 analysts, the average rating for ALC stock is "Buy." The 12-month stock price target is $95.55, which is an increase of 26.74% from the latest price.

Price Target
$95.55
(26.74% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon

CHARLOTTE, N.C. , Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1...

Other symbols: STAA
3 hours ago - PRNewsWire

Yunqi Capital, One of STAAR Surgical Company's Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon

HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...

Other symbols: STAA
23 hours ago - Business Wire

Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Judgment in Proposed Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (...

Other symbols: STAA
1 day ago - Business Wire

STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

Other symbols: STAA
1 day ago - Business Wire

Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical

SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breach...

Other symbols: STAA
4 days ago - GlobeNewsWire

Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical's Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or...

Other symbols: STAA
4 days ago - Business Wire

Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), th...

Other symbols: STAA
7 days ago - Business Wire

Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance

Alcon Inc. gets upgraded to a Buy again after my prior hold rating. Upside could come from macro-level clinical demand in the eyecare niche, but also a diverse and growing product portfolio in both th...

Other symbols: STAA
8 days ago - Seeking Alpha

STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

Other symbols: STAA
11 days ago - Business Wire

STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

Other symbols: STAA
15 days ago - Business Wire

Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company's Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon

HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...

Other symbols: STAA
15 days ago - Business Wire

STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

Other symbols: STAA
21 days ago - Business Wire

Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS

GENEVA--(BUSINESS WIRE)--Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS.

21 days ago - Business Wire

Eye care giant Alcon acquires LumiThera, a Seattle-area startup behind device that treats vision loss

LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on patients with dry age-related macular degeneration.

22 days ago - GeekWire

Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025

GENEVA--(BUSINESS WIRE)--Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025.

4 weeks ago - Business Wire

Alcon to Present at 2025 Baird Global Healthcare Conference

GENEVA--(BUSINESS WIRE)--Alcon to Present at 2025 Baird Global Healthcare Conference.

6 weeks ago - Business Wire

Trouble Ahead for Alcon Shares

Alcon Inc. is showing clear signs of weakness on its weekly chart. The stock has entered Phase 8 of its 18-phase Adhishthana cycle, and a critical breakdown from its Cakra formation has triggered what...

6 weeks ago - Benzinga

These Analysts Slash Their Forecasts On Alcon After Q2 Earnings

Alcon Inc ALC posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact.

6 weeks ago - Benzinga

Alcon Inc. (ALC) Q2 2025 Earnings Call Transcript

Alcon Inc. (NYSE:ALC) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Call Participants Daniel Cravens - Vice President of Investor Relations David J. Endicott - CEO & Director Timothy C.

6 weeks ago - Seeking Alpha

Alcon: More Than Meets The Eye

Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds like aging populations and technological advances. Recent M&A activity, including the STA...

6 weeks ago - Seeking Alpha

La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were slightly lower this morning, with the S&P 500 futures falling around 0.1% on Wednesday.

Other symbols: JHXLZB
6 weeks ago - Benzinga

Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit

The company said it expects a $100 million hit from tariffs this year.

6 weeks ago - WSJ

Alcon shares fall after it cuts guidance and warns of tariff impact

Shares in Alcon fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on Tuesday flagging the impact of U.S. tariffs.

6 weeks ago - Reuters

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical

GENEVA--(BUSINESS WIRE)--Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical.

Other symbols: STAA
6 weeks ago - Business Wire

Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS

AHMEDABAD, India--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the 37th Asia-Pacific Association of Cataract ...

7 weeks ago - Business Wire